CIK 0001808898 · Non-accelerated filer<br>Smaller reporting company
Benitec Biopharma Inc.
Sign in to watch- Ticker
- BNTC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- Phone
- (510) 780-0819
- Business address
- 3940 TRUST WAY, HAYWARD, CA, 94545
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 1,481,481 shares at $13.50 ($19,999,994)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Executive or director change · Regulation FD disclosure · Other events
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
Page 3 of 17 · 334 filings